Anti-idiotype vaccines to elicit catalytic antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 31, 2000
Grant Date -
N/A
app pub date -
Jun 22, 1998
filing date -
Jun 20, 1997
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed are methods for the production of second generation catalytic antibodies. The disclosed methods offer a variety of advantages relative to prior art techniques. For example, the methods of the present invention do not require prior identification of the active site of an enzyme, the activity of which is desired in the catalytic antibody. Additionally, the disclosed methods enable the production of antibodies which catalyze chemical reactions which do not occur in nature.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully